[NEU] YoY Quarter Result on 31-Dec-2018 [#Q4]

Stock
[NEU] Neuren Pharmaceuticals Limited
Announcement Date
30-Dec-2018
Financial Year
2018
Quarter
31-Dec-2018 [#Q4]
Profit Trend
QoQ- 275.02%
YoY- 4.81%
Quarter Report
NEU's Result
NEU's Financial Summary
View:
Show?
Quarter Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 3,197 717 495 13,990 631 2,988 61 93.33%
PBT -3,027 -5,149 -3,426 7,169 6,840 -3,773 -8,409 -15.64%
Tax -3,197 -717 -495 0 0 863 360 -
NP 170 -4,432 -2,931 7,169 6,840 -4,636 -8,049 -
Tax Rate - - - 0.00% 0.00% - - -
Total Cost 3,027 5,149 3,426 6,821 -6,209 7,624 8,110 -15.13%
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin 5.32 -618.13 -592.12 51.24 1,083.99 -155.15 -13,195.08 -
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
EPS 0.00 -0.04 -0.03 0.07 0.07 -0.06 -0.09 -
EPS Diluted 0.00 -0.04 -0.03 0.07 0.07 -0.06 -0.09 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.